RESEARCHER PROFILE
Walter Berger
← Back to Medical University of Vienna
W
Medical University of Vienna
Walter Berger works in Metal complexes synthesis and properties, Glioma Diagnosis and Treatment, Occupational and environmental lung diseases, Fibroblast Growth Factor Research, Lung Cancer Treatments and Mutations. Recorded institutional associations include Vienna General Hospital, Comprehensive Cancer Center Vienna, Center for Cancer Research.
788Publications
20,864Citations
71H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
2016 · 975 citationsKP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
2008 · 830 citationsNKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
2014 · 675 citationsAnticancer Activity of Metal Complexes: Involvement of Redox Processes
2011 · 554 citationsStructure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development
2017 · 425 citationsMetal Drugs and the Anticancer Immune Response
2018 · 354 citationsGreen tea extract and (−)‐epigallocatechin‐3‐gallate, the major tea catechin, exert oxidant but lack antioxidant activities
2005 · 313 citationsVaults and the major vault protein: Novel roles in signal pathway regulation and immunity
2008 · 253 citationsSpatio‐temporally precise activation of engineered receptor tyrosine kinases by light
2014 · 245 citationsResistance against novel anticancer metal compounds: Differences and similarities
2008 · 242 citationsPodoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism
2017 · 231 citationsHeterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
2004 · 200 citationsOphiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity
2013 · 183 citationsIntracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339
2010 · 173 citationsImpact of Metal Coordination on Cytotoxicity of 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone (Triapine) and Novel Insights into Terminal Dimethylation
2009 · 162 citationsSingle-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma
2020 · 155 citationsStructure−Activity Relationship Analysis of Novel Derivatives of Narciclasine (an Amaryllidaceae Isocarbostyril Derivative) as Potential Anticancer Agents
2009 · 152 citationsMechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds
2011 · 151 citationsAnticancer metal drugs and immunogenic cell death
2016 · 144 citationsOrganometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity
2013 · 141 citationsTarget profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action
2015 · 141 citationsMultidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications
2005 · 140 citationsTERTpromoter mutations are associated with poor prognosis and cell immortalization in meningioma
2018 · 140 citationsAnticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24)
2005 · 137 citationsAn albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo
2016 · 135 citations
